BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2525967)

  • 1. Abnormal in vitro differentiation of clonogenic B-cells in common acute lymphoblastic leukemia in complete remission. A marker for minimal residual disease?
    Bréard J; Mathé G; Consolini R
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):47-50. PubMed ID: 2525967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal in vitro differentiation of clonogenic B-cells in common acute lymphoblastic leukemia in complete remission. A marker for minimal residual disease?
    Bréard J; Mathé G; Consolini R
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():47-50. PubMed ID: 2977810
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormal in vitro differentiation of peripheral blood clonogenic B cells in common acute lymphoblastic leukemia during complete remission.
    Consolini R; Bréard J; Bourinbaiar A; Goutner A; Georgoulias V; Canon C; Brugerie E; Mathé G
    Blood; 1986 Mar; 67(3):796-801. PubMed ID: 2936409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J; Babusíková O; Kaiserová E; Jamárik M
    Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth requirements for human acute lymphoblastic leukemia cells: refinement of a clonogenic assay.
    Estrov Z; Freedman MH
    Cancer Res; 1988 Oct; 48(20):5901-7. PubMed ID: 3048651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of minimal residual disease in high risk childhood acute lymphoblastic leukemia using an immunological approach during complete remission. AIEOP Cooperative Group for Immunology of Acute Leukemias.
    Consolini R; Scamardella F; Legitimo A; Putti C; Granchi D; Paolucci P; Lippi A; Guazzelli C; Acquaviva A; Rosanda C
    Haematologica; 1993; 78(5):297-305. PubMed ID: 8314159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell colony assay improves the sensitivity of the cytogenetic analysis in common acute lymphoblastic leukemia.
    Consolini R; Legitimo A; Simi P; Bourinbaiar A
    Pathologica; 1994 Jun; 86(3):267-70. PubMed ID: 7808797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
    Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
    Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of continuous cultures of T-cell acute lymphoblastic leukemia cells at diagnosis.
    Gjerset R; Yu A; Haas M
    Cancer Res; 1990 Jan; 50(1):10-4. PubMed ID: 2152768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
    J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of residual acute lymphoblastic leukemia cells in cultures of bone marrow obtained during remission.
    Estrov Z; Grunberger T; Dubé ID; Wang YP; Freedman MH
    N Engl J Med; 1986 Aug; 315(9):538-42. PubMed ID: 3488505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
    Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
    J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization.
    Delia D; Cattoretti G; Bonati A; Villa S; De Braud F; Buscaglia M
    Clin Exp Immunol; 1985 Feb; 59(2):305-14. PubMed ID: 2579752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell phenotypic profile and colony formation during recovery from cytotoxic therapy-induced marrow aplasia.
    Ashkenazi YJ; Barth KC; Elfenbein GJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6513-8. PubMed ID: 3933827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.
    Caligaris-Cappio F; Bergui L; Tesio L; Pizzolo G; Malavasi F; Chilosi M; Campana D; van Camp B; Janossy G
    J Clin Invest; 1985 Sep; 76(3):1243-51. PubMed ID: 2931452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
    Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF
    Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric identification of intracellular antigens: detection of minimal residual leukemia.
    Gore S; Kastan M; Civin C
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():39-41. PubMed ID: 1697192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
    Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M
    Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia.
    Correale P; Tagliaferri P; Camera A; Caraglia M; Del Vecchio L; De Laurentis M; Pinto A; Rotoli B; Bianco AR
    Year Immunol; 1993; 7():90-5. PubMed ID: 7690510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.